JP2009518438A5 - - Google Patents

Download PDF

Info

Publication number
JP2009518438A5
JP2009518438A5 JP2008544572A JP2008544572A JP2009518438A5 JP 2009518438 A5 JP2009518438 A5 JP 2009518438A5 JP 2008544572 A JP2008544572 A JP 2008544572A JP 2008544572 A JP2008544572 A JP 2008544572A JP 2009518438 A5 JP2009518438 A5 JP 2009518438A5
Authority
JP
Japan
Prior art keywords
agent
stem cell
specific molecule
tumor stem
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008544572A
Other languages
English (en)
Other versions
JP2009518438A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/047136 external-priority patent/WO2007067795A2/en
Publication of JP2009518438A publication Critical patent/JP2009518438A/ja
Publication of JP2009518438A5 publication Critical patent/JP2009518438A5/ja
Withdrawn legal-status Critical Current

Links

Claims (10)

  1. 瘍幹細胞を阻害するための医薬の製造における腫瘍幹細胞特異的分子を化学的に修飾する剤の使用
  2. 腫瘍幹細胞特異的分子が合成されベル形の娘核に分離される、請求項1記載の使用
  3. 腫瘍幹細胞特異的分子が単鎖DNA(ssDNA)である、請求項1記載の使用
  4. が化学剤である、請求項1記載の使用
  5. が酵素である、請求項1記載の使用
  6. 者の腫瘍増殖を阻害するための医薬の製造における腫瘍幹細胞特異的分子を化学的に修飾する剤の使用
  7. 腫瘍幹細胞特異的分子が合成されベル形の娘核に分離される、請求項記載の使用
  8. 腫瘍幹細胞特異的分子が単鎖DNA(ssDNA)である、請求項記載の使用
  9. が化学剤である、請求項記載の使用
  10. が酵素である、請求項記載の使用
JP2008544572A 2005-12-09 2006-12-08 核形態に基づく腫瘍幹細胞の同定および標的のための方法 Withdrawn JP2009518438A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74895105P 2005-12-09 2005-12-09
PCT/US2006/047136 WO2007067795A2 (en) 2005-12-09 2006-12-08 Methods for identifying and targeting tumor stem cells based on nuclear morphology

Publications (2)

Publication Number Publication Date
JP2009518438A JP2009518438A (ja) 2009-05-07
JP2009518438A5 true JP2009518438A5 (ja) 2009-11-19

Family

ID=38099345

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008544572A Withdrawn JP2009518438A (ja) 2005-12-09 2006-12-08 核形態に基づく腫瘍幹細胞の同定および標的のための方法

Country Status (12)

Country Link
US (1) US20090304662A1 (ja)
EP (1) EP1963490A2 (ja)
JP (1) JP2009518438A (ja)
KR (1) KR20080079302A (ja)
CN (1) CN101426903A (ja)
AU (1) AU2006321710A1 (ja)
BR (1) BRPI0619599A2 (ja)
CA (1) CA2632754A1 (ja)
IL (1) IL191746A0 (ja)
RU (1) RU2008127844A (ja)
WO (1) WO2007067795A2 (ja)
ZA (1) ZA200804973B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101209833B1 (ko) * 2004-06-17 2012-12-07 메사추세츠 인스티튜트 오브 테크놀로지 핵 형태에 기초하여 줄기 세포를 동정하는 방법
JP5171945B2 (ja) * 2007-06-13 2013-03-27 マサチューセッツ インスティテュート オブ テクノロジー 腫瘍増殖を阻害する方法および薬剤
IT1392908B1 (it) 2008-09-29 2012-04-02 Italfarmaco Spa Uso degli inibitori delle istone-deacetilasi per la cura di sindromi mieloproliferative philadelphia-negative
US8217079B2 (en) 2010-03-26 2012-07-10 Italfarmaco Spa Method for treating Philadelphia-negative myeloproliferative syndromes
KR20140016241A (ko) 2010-10-25 2014-02-07 메사추세츠 인스티튜트 오브 테크놀로지 상처 치유 메타카리오틱 줄기 세포 및 그 사용방법
US20140369934A1 (en) * 2011-06-02 2014-12-18 Massachusetts Institute Of Technology dsRNA/DNA Hybrid Genome Replication Intermediate Of Metakaryotic Stem Cells
CN110118875B (zh) * 2019-05-09 2020-08-28 量准(武汉)生命科技有限公司 一种人类唾液中c型反应性蛋白彩色成像的方法及装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7361336B1 (en) * 1997-09-18 2008-04-22 Ivan Bergstein Methods of cancer therapy targeted against a cancer stem line
US6984522B2 (en) * 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
KR101209833B1 (ko) * 2004-06-17 2012-12-07 메사추세츠 인스티튜트 오브 테크놀로지 핵 형태에 기초하여 줄기 세포를 동정하는 방법

Similar Documents

Publication Publication Date Title
JP2009518438A5 (ja)
JP2008013542A5 (ja)
JP2009516517A5 (ja)
EP2001896A4 (en) MONOMER COMPOSITIONS FOR RNA SYNTHESIS, SYNTHESIS METHODS AND PROTECTION METHODS
EA201171335A1 (ru) Вектор гена
WO2011008730A3 (en) Chemical modification of small hairpin rnas for inhibition of gene expression
WO2008043521A3 (de) Microrna (mirna) zur diagnose und therapie von herzerkrankungen
EA201790824A3 (ru) Векторы для генной терапии и цитозиндезаминазы
IL194958A0 (en) Use of arylcarboxylic acid biphenylamides for seed treatment
WO2007121131A3 (en) Medical devices including shape memory materials
PL1935331T3 (pl) Proces przygotowania elektrod modyfikowanych, elektrod przygotowanych przy pomocy tego procesu i biosensory enzymatyczne zawierające takie elektrody
JP2007063263A5 (ja)
JP2008302206A5 (ja)
WO2008019372A3 (en) 2-aminobenzoxazole carboxamides as 5ht3 modulators
AP2413A (en) 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other disease.
JP2010509477A5 (ja)
EP1973945A4 (en) NEW NUCLEOTIDE AND AMINO ACID SEQUENCES AND METHOD FOR THEIR APPLICATION IN DIAGNOSIS
PT1922415E (pt) Uso de rd9 e is6110 como ácidos nucleicos-alvo para o diagnóstico da tuberculose, e fornecimento de alvos is6110 e rd9 compatíveis com uma utilização multiplex
NO20084177L (no) Substituerte Imidazo[2,1-B]thiazolforbindelser og deres anvendelse for produksjon av legemidler
JP2012509265A5 (ja)
HUP0600668A2 (en) Active carrier, process for producing thereof and the use of thereof
JP2008541745A5 (ja)
WO2008051523A3 (en) Carbazole derivatives useful as medicaments in cancer therapy
DK2089433T3 (da) Behandling, der er rettet mod cathepsin S
MY148254A (en) Tartrate derivatives for use as coagulation factor ixa inhibitors